School of Medicine (Sch. of Med.) Collections
Permanent URI for this collection
Browse
Recent Submissions
1 - 5 of 1363
-
ItemClinical Characteristics and Outcomes of Patients Admitted to Obstetric Intensive Care Units in Uganda: A Prospective Cohort Study.(Makerere University, 2026-11-13)Background : Obstetric critical illness comprises life-threatening conditions requiring intensive care, most commonly obstetric hemorrhage, hypertensive disorders of pregnancy, and sepsis. Maternal outcomes remain poorer in sub-Saharan Africa than in high-income countries, while available evidence is largely retrospective and limited, with Uganda lacking prospective obstetric ICU data. This study was therefore conducted to determine the clinical characteristics, seven-day outcomes, and factors associated with seven-day mortality among women admitted to obstetric ICUs in Uganda. Methods : Our study was an observational prospective cohort study among 165 consecutively recruited obstetric patients admitted to the Obstetric ICUs of two public hospitals in Kampala. All recruited participants were followed up until death, discharge, referral, or until 7 days, whichever came first. Clinical characteristics, seven-day outcomes, and factors associated with the outcomes were collected from all forms of available patient medical records. Data were summarised and analysed using bivariable and multivariable modified Poisson regression to determine the association between independent variables and the seven-day obstetric outcomes. Results The mean age was 28 years, with most women (71.5%) being multiparous with good antenatal care attendance (86.1%). Most (75.8%) were admitted during the early postpartum period. The most frequent reasons for ICU admission were obstetric haemorrhage (23%) and hypertensive disorders of pregnancy (32.7%). The majority (68.5%) of the patients were discharged from the unit within 7 days. The mortality rate was 10.3%. The median length of stay was two days (IQR: 1 - 3). Conclusion Obstetric critical illness in Uganda mainly affects young postpartum women with obstetric haemorrhage and hypertensive disorders of pregnancy. Respiratory failure, shock, and severe hemorrhage and/or coagulopathy were associated with increased seven-day obstetric ICU mortality. Keywords: obstetric intensive care; maternal critical illness; maternal mortality; postpartum;hemorrhage; hypertensive disorders; Uganda; prospective cohort.
-
ItemPrevalence and Factors Associated with Substance Use Disorders Among Patients with Bipolar Disorder at Butabika National Referral Mental Hospital.(Makerere University., 2026-06)Introduction: Substance use disorders (SUDs) frequently co-occur among patients with bipolar disorder (BD) in clinical settings, worsening clinical outcomes. However, local data on the prevalence and factors associated with SUDs in Ugandan patients with BD are limited. Aim: To determine the prevalence and factors associated with substance use disorders among patients with bipolar disorder at Butabika National Referral Mental Hospital in Uganda. Methodology: This cross-sectional study consecutively enrolled 404 adults with BD from outpatient and inpatient units. BD was confirmed using the Mini-International Neuropsychiatric Interview (MINI). SUDs were operationalised as moderate or high-risk scores on the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Suicidality risk and sociodemographic, clinical, psychosocial, and environmental data were collected. Multivariable logistic regression identified independently associated factors. Results: The overall prevalence of any SUD was 22.5%, primarily alcohol (17.3%), followed by cannabis (9.7%), tobacco (9.4%), and khat (2.7%). Easy access to substances (aOR=25.55) and a family history of SUD (aOR=11.41) were strongly associated with increased odds of any SUD. High suicidality risk was independently associated with tobacco, cannabis, khat, and any SUD (aOR=3.15). Female sex (aOR=0.31) and having a social support system (aOR=0.20) were protective. Conclusion: Nearly one-quarter of patients with BD had a co-occurring SUD. The strong link between SUDs and suicidality mandates concurrent screening and management of both in routine psychiatric care. Male patients and those with a family history of SUD, suicidality, or easy access to substances require prioritised intervention. To mitigate risk, clinical programmes should strengthen social support networks to promote SUD prevention, while health policies must address the environmental availability of substances.
-
ItemMortality and its predictors among TB patients within two years after TB treatment discharge at Kawaala and Kiswa Health Centre IVs, Kampala City, Uganda(Makerere university, 2026)Background: Tuberculosis (TB) treatment completion is an important indicator of programme success; however, this does not always indicate full recovery, and some patients die after treatment has ended. Evidence on the magnitude, timing and determinants of post-treatment mortality remains limited in routine Ugandan settings. This study assessed mortality among TB patients within two years after treatment discharge at Kawaala and Kiswa Health Centre IVs, Kampala City. Objective: To determine two-year mortality, potential predictors of mortality and time to mortality among TB patients after treatment discharge Methods: An ambispective cohort study included 259 eligible participants from a parent TB-diabetes cohort. Vital status was established from cohort and facility records, telephone follow-up and verbal-autopsy interviews with next of kin. Mortality was summarized as a cumulative proportion and person-time rate. Firth penalised logistic regression assessed potential predictors, while Kaplan–Meier and exploratory Cox proportional-hazards methods assessed survival and time to death Results: Participants contributed 6,036 person-months (503 person-years). Ten deaths occurred, giving a two-year cumulative mortality of 3.9% and a crude mortality rate of 19.9 deaths per 1,000 person-years. Five deaths occurred within 0–6 months and five during 6–12 months; none occurred during 12–24 months. Overall survival was 0.981 at six months and 0.961 at 12 months, remaining unchanged through 24 months. HIV-positive status was the strongest potential predictor of mortality across the Firth models (Model A: AOR 3.34, 95% CI 0.96–11.64; Model B: AOR 3.37, 95% CI 0.97–11.71) and the exploratory Cox model (AHR 3.41, 95% CI 0.98–11.84). Dysglycaemia did not show a clear prognostic relationship with mortality (AHR 1.12, 95% CI 0.23–5.54). All adjusted estimates were imprecise because only 10 deaths occurred Conclusion: Post-treatment mortality was relatively low but was concentrated entirely within the first year. HIV-positive status showed the strongest potential predictor signal, although the estimates remained imprecise. The findings support evaluating structured first-year post-TB follow-up and mortality surveillance, with particular attention to continuity of HIV care among HIV-positive survivors. Larger multicentre prospective studies are needed to confirm predictors of mortality and improve precision and generalizability.
-
ItemAssessment of Plasmodium falciparum genetic diversity, multiplicity of infection and algorithms for distinguishing recrudescence from reinfection in antimalarial drug efficacy studies in Uganda(Makerere University, 2025-06-10)Background: Despite renewed control efforts, malaria remains a major public health problem, contributing significantly to morbidity and mortality, especially in endemic countries. Effective control is hindered by several factors, including the high genetic diversity of Plasmodium falciparum, the presence of multiple parasite clones within a single host (referred to as multiplicity of infection (MOI)), and the persistence of parasite strains despite treatment (recrudescence). This PhD study aimed to assess P. falciparum genetic diversity and MOI with in sub-Saharan Africa (SSA), with a specific focus on areas of varying malaria transmission intensity in Uganda. Additionally, we evaluated the performance of different microsatellite markers and genotyping algorithms in distinguishing recrudescence from reinfection, an essential component of antimalarial drug efficacy monitoring. Methods: This study employed a combination of systematic review, meta-analysis, and secondary data analysis using both cross-sectional and longitudinal studies. To evaluate P.falciparum genetic diversity and MOI across different geographical regions in SSA (Objective 1), I conducted a systematic review and meta-analysis of published articles. The review focused on studies using common molecular markers, including genes of merozoite surface protein 1 and 2 (msp-1, msp-2), and microsatellites. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. To determine how P. falciparum genetic diversity and MOI vary by malaria transmission intensity, clinical disease status (asymptomatic versus symptomatic), and over time (Objectives 2, 3, and 4), I performed secondary analyses of data and dried blood spot (DBS) filter paper samples from comprehensive surveillance studies conducted between 2011 and 2017 in areas of varying transmission intensities in Uganda. To assess the performance of microsatellite markers and three genotyping algorithms (3/3 match-counting, ≥2/3 matchxiii counting, and the Bayesian approach) in distinguishing between recrudescence and reinfection (Objective 5), I analyzed data and DBS filter paper samples from a therapeutic efficacy study (TES) conducted between September 2018 and February 2019 at three health centers located in high malaria transmission regions of Uganda. Demographic and clinical data were retrieved from primary study databases, while genetic data were generated through genotyping of P. falciparum isolates using the highly polymorphic markers msp-1, msp-2, and microsatellites. Genomic DNA was extracted from DBS samples using Chelex 100 Resin (Sigma-Aldrich, USA). Genotyping of msp-1, msp-2, and glurp was performed using nested PCR, with amplicon sizing on the QIAxcel Advanced System (QIAGEN). For microsatellites, seven loci (TA1, Poly-α, PfPK2, TA109, 2490, C2M34–313, and C3M69–383) were amplified using fluorescently labeled primers, and allele sizing was conducted via high-resolution capillary electrophoresis on an ABI 3730 Genetic Analyzer. P. falciparum genetic diversity was assessed by calculating allele count, effective allele number, allelic richness, and expected heterozygosity (He). P. falciparum MOI was estimated by determining the number of distinct genotypes per infection. Population structure was assessed using multilocus linkage disequilibrium (LD), genetic differentiation, analysis of molecular variance (AMOVA), and clustering analysis. Statistical comparisons were made using the Kruskal–Wallis test, Chi-square test, or Fisher’s exact test, as appropriate. Temporal trends were analyzed using the Jonckheere–Terpstra test, while genotyping algorithm performance was assessed using the Wilcoxon signed-rank test. For all analyses, 95% confidence intervals and/or standard deviations were reported where applicable, with statistical significance set at p < 0.05. Results: The systematic review and meta-analysis showed significant regional variation in P. falciparum genetic diversity and MOI across SSA. The pooled mean He was 0.65 (95% CI: 0.51–0.78), and the pooled mean MOI was 2.09 (CI: 1.88–2.30), with 63% (CI: 56–70%) of cases showing polyclonal infections. When P. falciparum genetic diversity was compared between areas with different malaria transmission intensities in Uganda, no statistically significant variation was observed across sites (p > 0.05), though Kanungu (a low transmission site) showed the highest mean He (0.81 ± 0.14), while the mean He was slightly lower and similar in both Jinja and Tororo (both 0.78 ± 0.16). Regarding MOI, Tororo, a high-transmission site, exhibited a significantly higher mean MOI (2.5 ± 0.5) and polyclonal infection rate (70%) compared to Kanungu (MOI: 2.0 ± 0.05; polyclonal rate: 56%) and Jinja (MOI: 1.9 ± 0.3; polyclonal rate: 58%) (p = 0.004). Genetic structure analysis indicated minimal differentiation (FST: 0.011–0.021). When comparing P. falciparum genetic diversity and MOI between asymptomatic and symptomatic participants, both groups exhibited high genetic diversity (He 0.79–0.81). Polyclonal infections were common in both groups (58.5% in symptomatic and 63% in asymptomatic). Asymptomatic participants had a higher mean MOI (2.10) than symptomatic individuals (1.92), though the difference was not statistically significant (p = 0.33). Temporal analyses showed a slight decline in He from 0.79 to 0.76, with polyclonal infections remaining above 50% throughout the period. Finally, the 3/3 match-counting algorithm identified significantly fewer recrudescence cases compared to the ≥2/3 match-counting and Bayesian algorithms (p < 0.001). Conclusions: This study shows significant regional variation in P. falciparum genetic diversity and MOI within SSA. Within Uganda, genetic diversity of P. falciparum did not differ significantly across sites, although MOI varied significantly by transmission intensity. Persistently high genetic diversity, minimal population differentiation, and sustained polyclonal infections were observed across clinical disease status and time, reflecting ongoing transmission pressures rather than uniform regional variation. Discrepancies in recrudescence classification between match-counting and Bayesian algorithms highlight the need for standardized PCR correction practices. These findings underscore the need for tailored malaria control strategies, including targeted interventions for asymptomatic carriers and continuous molecular surveillance to adapt to evolving transmission dynamics. Furthermore, the study emphasizes the importance of using robust analytical algorithms to accurately distinguish recrudescence from reinfection, an essential component of effective antimalarial drug efficacy monitoring.
-
ItemAcceptance of Malaria Vaccine and its Determinants among Caregivers of Children under 5 Years at Mulago National Referral Hospital-a Mixed Methods Study.(Makerere university, 2026-10-11)Background: Malaria remains a major public health challenge in Uganda. Although the malaria vaccine offers a promising additional control measure, its successful uptake depends on caregiver acceptance. There’s a critical gap in understanding caregivers’ willingness to accept the vaccine which poses a challenge in effective vaccine implementation. Objective: To investigate the acceptance, knowledge, and perceptions of the malaria vaccine among caregivers of children under the age of five attending Mulago National Referral Hospital. Methodology: This was a convergent parallel mixed methods cross- sectional study. The quantitative component involved a cross-sectional survey of 385 caregivers of children under five attending the Paediatrics Outpatient Clinic at Mulago National Referral Hospital, selected through systematic sampling. An interviewer administered questionnaire was used to collect data on willingness to accept the malaria vaccine, knowledge and perceptions. The qualitative component comprised in-depth interviews with 24 caregivers, selected purposively. Qualitative data was analysed using thematic content analysis. Results: Vaccine acceptance was high at 86.5% though this fell markedly when a hypothetical fee was introduced. Good vaccine knowledge was the strongest independent predictor of acceptance (aOR 2.658, 95% CI: 1.005-7.033, p=0.049). Health worker contact (aOR 2.984, 95%CI: 1.146-7.775, p=0.025) was the primary independent predictor of knowledge. Caregivers perceived the malaria vaccine as beneficial for immunity and cost reduction but expressed safety concerns and unrealistic expectations. Despite high acceptance driven by high malaria burden and trust in government programs, hesitancy persisted due to fear of side effects and negative experiences from COVID 19 spill over within a contested social environment. Conclusions: Malaria vaccine acceptance was near universal but conditional on free delivery and vulnerable to safety misinformation and cross-vaccine distrust. Knowledge was the most critical modifiable determinant of acceptance and health workers were its most powerful driver. Structured health worker counselling and preservation of cost-free vaccine delivery even in an urban setting are essential to translating high acceptance intent into complete, schedule adherent vaccine uptake.